Rockbridge Investment Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-120
| Closed | -$3.94K | – | 154 |
|
|
2023
Q4 | $3.94K | Buy |
+120
| New | +$3.94K | ﹤0.01% | 489 |
|
|
2022
Q3 | – | Sell |
-290
| Closed | -$9.13K | – | 132 |
|
|
2022
Q2 | $9.13K | Hold |
290
| – | – | ﹤0.01% | 371 |
|
|
2022
Q1 | $13.9K | Hold |
290
| – | – | ﹤0.01% | 461 |
|
|
2021
Q4 | $18K | Hold |
290
| – | – | ﹤0.01% | 489 |
|
|
2021
Q3 | $22K | Hold |
290
| – | – | ﹤0.01% | 436 |
|
|
2021
Q2 | $27K | Hold |
290
| – | – | ﹤0.01% | 398 |
|
|
2021
Q1 | $26K | Sell |
290
-180
| -38% | -$16.1K | ﹤0.01% | 376 |
|
|
2020
Q4 | $44K | Buy |
+470
| New | +$44K | 0.01% | 300 |
|